HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regina Katzenschlager Selected Research

Apomorphine

1/2021Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study.
1/2018Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
12/2016Apomorphine - pharmacological properties and clinical trials in Parkinson's disease.
9/2015Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.
4/2015EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
1/2011Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect.
2/2005Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
9/2002Treatment of Parkinson's disease: levodopa as the first choice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Regina Katzenschlager Research Topics

Disease

24Parkinson Disease (Parkinson's Disease)
02/2022 - 09/2002
11Dyskinesias (Dyskinesia)
01/2018 - 09/2002
6Parkinsonian Disorders (Parkinsonism)
06/2009 - 04/2003
3Fatigue
02/2022 - 01/2011
3Dystonia (Limb Dystonia)
09/2015 - 12/2002
3Dementia (Dementias)
11/2013 - 10/2011
2Movement Disorders (Movement Disorder)
02/2022 - 05/2020
2Hallucinations (Hallucination)
01/2011 - 09/2002
2Tremor (Tremors)
12/2005 - 04/2003
1Pain (Aches)
02/2022
1COVID-19
05/2020
1Constipation
10/2011
1Gambling (Pathological Gambling)
10/2011
1Disorders of Excessive Somnolence (Hypersomnia)
10/2011
1Orthostatic Hypotension (Postural Hypotension)
10/2011
1Erectile Dysfunction
10/2011
1Sleep Initiation and Maintenance Disorders (Insomnia)
10/2011
1Psychotic Disorders (Schizoaffective Disorder)
10/2011
1Sialorrhea
10/2011
1Illusions (Auditory Illusions)
01/2011
1Nocturia
01/2011
1Hyperhidrosis
01/2011
1Drug-Induced Dyskinesia (Dyskinesia, Drug Induced)
02/2005
1Phenylketonurias (Phenylketonuria)
10/2004
1Mania (Manias)
04/2004
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
04/2004
1Dysarthria (Spastic Dysarthria)
09/2002
1Cognitive Dysfunction
09/2002

Drug/Important Bio-Agent (IBA)

14Levodopa (L Dopa)FDA LinkGeneric
01/2018 - 09/2002
8ApomorphineFDA Link
01/2021 - 09/2002
4Dopamine Agonists (Dopamine Agonist)IBA
12/2016 - 09/2002
42- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
06/2009 - 12/2002
3Amantadine (Aman)FDA LinkGeneric
01/2018 - 07/2010
3Clozapine (Clozaril)FDA LinkGeneric
01/2018 - 10/2011
2Donepezil (Aricept)FDA LinkGeneric
09/2012 - 10/2011
2Pramipexole (Mirapex)FDA LinkGeneric
10/2011 - 10/2011
2Pergolide (Permax)FDA Link
10/2011 - 10/2011
2Pharmaceutical PreparationsIBA
05/2010 - 07/2004
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
06/2009 - 10/2004
1safinamideIBA
02/2022
1Glutamic Acid (Glutamate)FDA Link
02/2022
1Endopeptidase K (Proteinase K)IBA
11/2013
1Prion ProteinsIBA
11/2013
1Cholinergic Agents (Cholinergics)IBA
09/2012
1Memantine (Namenda)FDA Link
10/2011
1Methylphenidate (Ritalin)FDA LinkGeneric
10/2011
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
10/2011
1Nortriptyline (Aventyl)FDA LinkGeneric
10/2011
1Antidepressive Agents (Antidepressants)IBA
10/2011
1batrachotoxinin A 20-alpha-benzoateIBA
10/2011
1ropinirole (Requip)FDA LinkGeneric
10/2011
1nefazodone (Serzone)FDA LinkGeneric
10/2011
1Sildenafil Citrate (Viagra)FDA Link
10/2011
1Rivastigmine (Exelon)FDA LinkGeneric
10/2011
1Quetiapine Fumarate (Seroquel)FDA Link
10/2011
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2011
1Eszopiclone (Lunesta)FDA Link
10/2011
1Olanzapine (Zyprexa)FDA Link
10/2011
1Modafinil (Provigil)FDA Link
10/2011
1CabergolineFDA LinkGeneric
10/2011
1Amitriptyline (Elavil)FDA LinkGeneric
10/2011
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
10/2011
1Carbidopa (Lodosyn)FDA LinkGeneric
10/2011
1Desipramine (Pertofrane)FDA LinkGeneric
10/2011
1Domperidone (Domperidon)IBA
10/2011
1Fatty Acids (Saturated Fatty Acids)IBA
10/2011
1FludrocortisoneIBA
10/2011
1Fluoxetine (Prozac)FDA LinkGeneric
10/2011
1Galantamine (Galanthamine)FDA LinkGeneric
10/2011
1Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
10/2011
1MelatoninIBA
10/2011
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
10/2011
1CitalopramFDA LinkGeneric
10/2011
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2011
1Paroxetine (Paxil)FDA LinkGeneric
10/2011
1Type A Botulinum Toxins (Botox)FDA Link
10/2011
1Sertraline (Zoloft)FDA LinkGeneric
10/2011
1Transcription Factors (Transcription Factor)IBA
02/2011
1AMPA Receptors (AMPA Receptor)IBA
05/2010
1perampanelIBA
05/2010
14- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
06/2009
1Leucine (L-Leucine)FDA Link
08/2007
1Phosphotransferases (Kinase)IBA
08/2007
1BenserazideIBA
04/2007
1glycine amideIBA
04/2007
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2007
1NeuropeptidesIBA
04/2007
1Dopamine Receptors (Dopamine Receptor)IBA
02/2005
1Dopamine (Intropin)FDA LinkGeneric
04/2004
1Dopamine Agents (Dopaminergic Agents)IBA
09/2002

Therapy/Procedure

9Therapeutics
05/2020 - 09/2002
3Subcutaneous Infusions
01/2018 - 01/2011
1Transcranial Magnetic Stimulation
10/2011
1Drug Therapy (Chemotherapy)
05/2010